What drugs does WOCKHARDT EU OPERATN make?

WOCKHARDT EU OPERATN has 1 FDA-approved drugs.

What therapeutic areas does WOCKHARDT EU OPERATN focus on?

WOCKHARDT EU OPERATN focuses primarily on Infectious Disease and Dermatology.

← Back

Data updated: Mar 10, 2026

WOCKHARDT EU OPERATN

Infectious DiseaseDermatology

Generics

WOCKHARDT EU OPERATN is a generic drug manufacturer focused on Infectious Disease, Dermatology.

1999

Since

Drugs

Trials

Approved (2yr)

Key Drugs

No active drugs

Recent Activity

ALBUTEROL SULFATE 2025-12-01

ALBUTEROL SULFATE 2025-11-21

Labeling

ALBUTEROL SULFATE 2025-03-12

ALBUTEROL SULFATE 2024-05-21

ALBUTEROL SULFATE 2024-05-03

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 75%

0 drugs Phase 3: 2 Phase 2: 1 Phase 1: 2

Dermatology 25%

0 drugs Phase 3: 1

Pipeline Strength ProEarly access

Competitors ProEarly access

Pfizer big-pharma

Infectious Disease, Dermatology

Baxter specialty

Infectious Disease, Dermatology

B BRAUN specialty

Infectious Disease, Dermatology

COSETTE other

Dermatology, Infectious Disease

BAUSCH AND LOMB specialty

Infectious Disease, Dermatology

WOCKHARDT EU OPERATN

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (1)

Active (1)

Discontinued (0)

Company Info